Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Hanxu HongDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0009-0005-0937-429X
Yuxuan LiuDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0000-0003-1239-0539
Linping FanDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Bowen ShiFirst Clinical Medical College, Nanchang University, Nanchang, China.
Ruihang LuoFirst Clinical Medical College, Nanchang University, Nanchang, China.
Chenye XiCollege of Stomatology, Nanchang University, Nanchang, China.
Zhuoyuan YangSecond Clinical Medical College, Nanchang University, Nanchang, China.
Wenjing YangFirst Clinical Medical College, Nanchang University, Nanchang, China.
Xinyi ZengFirst Clinical Medical College, Nanchang University, Nanchang, China.
DanDan WeiDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yang LiuDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0009-0009-1869-3558
Funding
National Natural Science Foundation of China 32370195National Natural Science Foundation of China 82102411National Natural Science Foundation of China 82260403
6 · The paper itself
Abstract
Low-level cefiderocol (CFDC) resistance in carbapenem-resistant
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Occurrence of KPC-71 or the presence of NDM combined with a high expression of · full record | OpenQuestion